BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Inflammatory disorder
,
Pancreas
,
Biofuel
,
Doxorubicin
,
rs3825942
,
SLC12A1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gene products, tat
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CCL3
FREM2
CD1E
CD93
SSX1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
CHEN_METABOLIC_SYNDROM_NETWORK
MODULE_84
immune response
MODULE_75
MODULE_46
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T lymphocytes treated with HIV Tat protein
Chronic myeloid leukemia RPMI8866 cells ectopically expressing HIV-1 mutant TAT C22G protein
Neuronal cortical cultures treated with HIV recombinant TAT (1–86), DDX3 inhibitor RK33 & cocaine
CD4+ T cells expressing constitutively full-length or first-exon Tat protein of HIV-1
Explore Curated Studies Results
Literature
Most Relevant Literature
HIV-1 Tat Protein-Mediated Inflammatory Response Inhibits the Erythroid Hematopoietic Support Functi…
TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome.
T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein.
Analysis of Tat protein characteristics in human immunodeficiency virus type 1 sub-subtype A6 (Retro…
In vitro Anti-HIV-1 Activity of the Recombinant HIV-1 TAT Protein Along With Tenofovir Drug.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infec…
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patient…
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted E…
A Gene Therapy Study for Hemophilia B
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ